Hand's Pick
Merck Drops $9.2 Billion on Experimental Flu Drug — Could This Save Its Post-Keytruda Future?
Merck Stuns Wall Street With $9.2 Billion Bet In a jaw-dropping move, Merck is acquiring Cidara Therapeutics for $9.2 billion, sending shockwaves through the pharmaceutical world. The prize? An experimental…
Latest News
Alone at 15, Working Four Jobs, Now an $8 Billion Founder: Inside Jack Zhang’s Rise
Success stories often sound glamorous, but Jack Zhang’s journey began with survival, not ambition. Long before becoming the co-founder and…
A Fragile Truce: Why Wall Street Is Watching Trump’s Every Move
The Fragile Peace Between Trump and the $30 Trillion U.S. Bond Market The uneasy relationship between President Donald Trump and…
Coffee Day Shares Jump 25% In Three Days
Stocks of Coffee Day Enterprises Ltd (CDEL), parent of the popular Cafe Coffee Day chain, have rallied a whopping 25.33%…
Maruti Suzuki Announces Price Hike for Cars in January 2024, Following Audi’s Move
Maruti Suzuki, India's largest carmaker, revealed on Monday its decision to increase the prices of its cars starting January 2024.…
